Functional anatomy and immunological interactions of ocular surface and adnexa

Developments in Ophthalmology

Volumn 41, Issue , 2008, Pages 21-35

  Paulsen, F ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUNCTIVA; CORNEA; DRY EYE; EYELID; HISTOLOGY; HUMAN; IMMUNOLOGY; LACRIMAL APPARATUS; LYMPHOID TISSUE; MUCOSAL IMMUNITY; PHYSIOLOGY; REVIEW;

CONJUNCTIVA; CORNEA; DRY EYE SYNDROMES; EYELIDS; HUMANS; IMMUNITY, MUCOSAL; LACRIMAL APPARATUS; LYMPHOID TISSUE;

EID: 47949132082     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000131068     Document Type: Review

References (56)

1. Gipson IK, Hori Y, Argüeso P: Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf 2004;2:131-148.
2. Jumblatt MM, McKenzie RW, Steele PS, Emberts CG, Jumblatt JE: MUC7 expression in the human lacrimal gland and conjunctiva. Cornea 2003;22:41-45.
3. Paulsen F, Langer G, Hoffmann W, Berry M: Human lacrimal gland mucins. Cell Tissue Res 2004;316:167-177.
4. Paulsen F: Cell and molecular biology of human lacrimal gland and nasolacrimal duct mucins. Int Rev Cytol 2005;249:229-279.
5. Paulsen F, Berry M: Mucins and TFF peptides of the tear film and lacrimal apparatus. Prog Histochem Cytochem 2006;41:1-53.
6. Langer G, Jagla W, Behrens-Baumann W, Walter S, Hoffmann W: Secretory peptides TFF1 and TFF3 synthesized in human conjunctival goblet cells. Invest Ophthalmol Vis Sci 1999;40: 2220-2224.
7. Hoffmann W, Jagla W: Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int Rev Cytol 2002;213:147-181.
8. Paulsen F, Varoga D, Steven P, Pufe T: Antimicrobial peptides at the ocular surface; in Zierhut M, Stern ME, Sullivan DA (eds): Immunology of Lacrimal Gland and Tear Film. London, Taylor & Francis, 2005, pp 97-104.
9. McDermott: Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf 2004;2: 229-247.
10. Steven P, Schäfer G, Nölle B, Hinz M, Hoffmann W, Paulsen F: Distribution of TFF peptides in corneal disease and pterygium. Peptides 2004;25:819-825.
11. Akiyama J, Hoffman A, Brown C, Allen L, Edmondson J, Poulain F, Hawgood S: Tissue distribution of surfactant proteins A and D in the mouse. J Histochem Cytochem 2002;50:993-996.
12. Bräuer L, Kindler C, Jäger K, Sel S, Nölle B, Pleyer U, Ochs M, Paulsen F: Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system. Invest Ophthalmol Vis Sci 2007;48:3945-3953.
13. McCulley JP, Shine WE: Meibomian gland function and the tear lipid layer. Ocul Surf 2003;1:97-106.
14. Sullivan DA, Sullivan BD, Ullman MD, Rocha EM, Krenzer KL, Cermak JM, Toda I, Doane MG, Evans JE, Wickham LA: Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 2000;41:3732-3742.
15. Stoeckelhuber M, Stoeckelhuber BM, Welsch U: Human glands of Moll: histochemical and ultrastructural characterization of the glands of Moll in the human eyelid. J Invest Dermatol 2003;121: 28-36.
16. Paulsen F, Thale A, Kohla G, Schauer R, Rochels R, Parwaresch R, Tillmann B: Functional anatomy of human duct epithelium. Anat Embryol 1998;198:1-12.
17. Paulsen F, Corfield A, Hinz M, Hoffmann W, Schaudig U, Thale A, Berry M: Characterization of mucins in human lacrimal sac and nasolacrimal duct. Invest Ophthalmol Vis Sci 2003;44:1807-1813.
18. Paulsen F, Hinz M, Schaudig U, Thale AB, Hoffmann W: TFF peptides in the human efferent tear ducts. Invest Ophthalmol Vis Sci 2002;43:3359-3364.
19. Paulsen F, Pufe T, Schaudig U, Held-Feindt J, Lehmann J, Schröder J-M, Tillmann B: Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci 2001;42:2157-2163.
20. Paulsen F, Föge M, Thale A, Tillmann B, Mentlein R: Absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts. Invest Ophthalmol Vis Sci 2002;43:3137-3143.
21. Ayub M, Thale A, Hedderich J, Tillmann B, Paulsen F: The cavernous body of the human efferent tear ducts functions in regulation of tear outflow. Invest Ophthalmol Vis Sci 2003;44:4900-4907.
22. Paulsen F, Paulsen J, Thale A, Tillmann B: Mucosa-associated lymphoid tissue in the human efferent tear ducts. Virchows Arch 2000;437:185-189.
23. Paulsen F, Schaudig U, Thale A: Drainage of tears: impact on the ocular surface and lacrimal system. Ocul Surf 2003;1:180-191.
24. Belmonte C, Aracil A, Acosta C, Luna C, Gallar J: Nerves and sensations from the eye surface. Ocul Surf 2004;2:248-253.
25. Stern ME, Beuermann RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC: The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-589.
26. Paulsen F, Thale A, Hallmann U, Schaudig U, Tillmann B: The cavernous body of the human efferent tear ducts - function in tear outflow mechanism. Invest Ophthalmol Vis Sci 2000;41:965-970.
27. Sack RA, Nunes I, Beaton A, Morris C: Host-defense mechanism of the ocular surfaces. Biosci Rep 2001;21:463-480.
28. Mircheff AK: Sjögrens syndrome as failed local immunohomeostasis: prospects for cell-based therapy. Ocul Surf 2003;1:160-179.
29. Franklin RM: The ocular secretory immune system: a review. Curr Eye Res 1989;8:599-606.
30. Brandtzaeg P: Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections. J Infect Dis 1992;165(suppl 1):167-176.
31. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 1996;272:60-66.
32. Isaacson PG: Extranodal lymphomas: the MALT concept. Verh Dtsch Ges Pathol 1992;76:14-23.
33. Österlind G: An investigation into the presence of lymphatic tissue in the human conjunctiva, and its biologic and clinical importance. Acta Ophthalmol 1944;23:1-79.
34. Wotherspoon AC, Hardman-Lea S, Isaacson PG: Mucosa-associated lymphoid tissue in the human conjunctiva. J Pathol 1994;174:33-37.
35. Hingorani M, Metz D, Lightman SL: Characterisation of the normal conjunctival leukocyte population. Exp Eye Res 1997;64:905-912.
36. Chodosh J, Nordquist RE, Kennedy RC: Comparative anatomy of mammalian conjunctival lymphoid tissue: a putative mucosal immune site. Dev Comp Immunol 1998;22:621-630.
37. Paulsen F, Paulsen J, Thale A, Schaudig U, Tillmann B: Organized mucosa-associated lymphoid tissue in human nasolacrimal ducts. Adv Exp Med Biol 2002;506:873-876.
38. Paulsen F, Schaudig U, Maune S, Thale AB: Loss of tear duct-associated lymphoid tissue in association with the scarring of symptomatic dacryostenosis. Ophthalmology 2003;110:85-92.
39. Knop N, Knop E: Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 2000;41:1270-1279.
40. Knop E, Knop N: Lacrimal drainage-associated lymphoid tissue: a part of the human mucosal immune system. Invest Ophthalmol Vis Sci 2001;42:566-574.
41. Knop E, Knop N: Augen-assoziiertes lymphatisches Gewebe (EALT) durchzieht die Augenoberfläche kontinuierlich von der Tränendrüse bis in die ableitenden Tränenwege. Ophthalmologe 2003;100: 929-942.
42. Shirai Y: Immune surveillance. Jap Med World 1921;1:1-4.
43. Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948;29:58-69.
44. Streilein JW: Peripheral tolerance induction: lessons from immune privileged sites and tissues. Transplant Proc 1996;28:2066-2070.
45. Streilein JW, Niederkorn JY: Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation induced in BALB/c mice by P815 cells. J Immunol 1985;134:1381-1387.
46. Yamagami S, Dana R: The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 2001;42:1293-1298.
47. Axelrod AJ, Chandler JW: Morphologic characteristics of conjunctival lymphoid tissue in the rabbit; in Silverstein AM, O'Connor GR (eds): Immunology and Immunopathology of the Eye. New York, Mason, 1979, pp 292-301.
48. Chodosh J, Nordquist RE, Kennedy RC: Anatomy of mammalian conjunctival lymphoepithelium. Adv Exp Med Biol 1998;438:557-565.
49. Dua HS, Gomes JAP, Jindal VK, Appa SN, Schwarting R, Eagle RC Jr, Donoso LA, Laibson PR: Mucosa-specific lymphocytes in the human conjunctiva, corneoscleral limbus and lacrimal gland. Curr Eye Res 1994;13:87-93.
50. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Storozynsky E, Lord EM, Frelinger JG, Woodward JG: In vivo behaviour of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T-cell priming followed by anergy. J Immunol 2000;164:4543-4550.
51. Giuliano EA, Moore CP, Philips TE: Morphological evidence of M cells in healthy canine conjunctiva-associated lymphoid tissue. Graefes Arch Clin Exp Ophthalmol 2002;240:220-226.
52. Hathway LJ, Kraehenbuhl JP: The role of M cells in mucosal immunity. Cell Mol Life Sci 2000;57:323-332.
53. Gao J, Schwab TA, Addeo JV, Ghosn CR, Stern ME: The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical cyclosporin A therapy. Cornea 1998;17: 654-663.
54. Azzarolo AM, Wood RL, Mircheff AK, Richters A, Olsen E, Berkowitz M, Bachmann M, Huang ZM, Zolfagari R, Warren DW: Androgen influence on lacrimal gland apoptosis, necrosis, and lymphocytic infiltration. Invest Ophthalmol Vis Sci 1999;40:592-602.
55. Sullivan DA, Krenzer KL, Sullivan BD: Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? Invest Ophthalmol Vis Sci 1999;40:1261-1265.
56. Alpan O, Rudomen G, Matzinger P: The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J Immunol 2001;166:4843-4852.